Bgl8.0

Beta-Glucans

Beta-Glucans (1,3/1,6)

Polysaccharides from yeast, mushrooms, or oats that powerfully modulate immune function with strong clinical evidence.

immuneimmunityimmune modulationinnate immunityinfection resistancecholesterol
Last reviewed: January 1, 2025
8.0/10
40+ studies
Evidence
high
Safety
250-500mg yeast beta-glucan OR 3g oat beta-glucan for cholesterol
Dose
4-12 weeks
Time to Effect
Yeast-derived 1,3/1,6 beta-glucan (Wellmune is most studied)
Best Form

Beta-glucans are glucose polymers found in the cell walls of yeast, fungi, oats, and barley. The 1,3/1,6 forms from yeast and mushrooms are potent immune modulators, while oat beta-glucans primarily lower cholesterol. They train the innate immune system to respond more effectively to pathogens without overstimulation. Among the most well-researched immune supplements.

Mechanisms of Action

🎯
Trained Immunity

Primes innate immune cells for faster response

🦠
Macrophage Activation

Activates first-line immune defenders

📉
Cholesterol Binding (Oat)

Binds bile acids to lower cholesterol

Recommended Dose

250-500mg yeast beta-glucan OR 3g oat beta-glucan for cholesterol

100mg1000mg

Optimal Timing

  • Morning
  • With or without food

Can be taken without food

Best Form

Yeast-derived 1,3/1,6 beta-glucan (Wellmune is most studied)

Alternatives: Mushroom-derived beta-glucans, Oat beta-glucan (for cholesterol)

Wellmune is the most clinically validated for immune support. Oat beta-glucan is specifically for cholesterol.

Duration

Minimum: 4 weeks

Optimal: 12 weeks

Cycling: Not required

Note: Yeast beta-glucan can be taken any time. Oat beta-glucan for cholesterol should be taken with meals.

Personalized Dosage Calculator

Get a dosage recommendation tailored to your body weight, age, goals, and health profile.

Set up your health profile for personalized recommendations

🛡️
Fewer Infections

Reduced incidence of colds and respiratory infections

4-12 weeks
65% of users notice thispositive
⚡
Faster Recovery

Shorter duration of illness

During illness
55% of users notice thispositive
📉
Cholesterol Reduction

Lower LDL (oat beta-glucan)

4-8 weeks
60% of users notice thispositive
High SafetyMax safe dose: Up to 1000mg yeast beta-glucan/day
🟡
Autoimmune conditions

Consult doctor — immune modulation may not be appropriate

Who Should NOT Take This

  • Known allergy or hypersensitivity to Beta-Glucans or related compounds

Drug Interactions

Immunosuppressantsmoderate

May counteract immunosuppressive effects — consult doctor

Possible Side Effects

Bloating/gasuncommon

Tip: Reduce dose; more common with oat beta-glucan

Warnings

  • Not recommended for those on immunosuppressant medications
  • Consult doctor if you have autoimmune conditions

Top studies from 40+ peer-reviewed papers

meta-analysisn=2685
DOI

Juhász AE et al. • The American journal of clinical nutrition (2023)

“Galactomannans were the most effective dietary fiber for reducing the levels of HbA1c, fasting blood glucose, triglycerides, and LDL cholesterol in patients with type 2 diabetes.”
Key Findings:
  • Galactomannans had the highest effect on reducing the levels of HbA1c (SUCRA: 92.33%) and fasting blood glucose (SUCRA: 85.92%).
  • With regard to fasting insulin level, HOMA-IR, β-glucans (SUCRA: 73.45%), and psyllium (SUCRA: 96.67%) were the most effective interventions.
  • Galactomannans were ranked first in reducing the levels of triglycerides (SUCRA: 82.77%) and LDL cholesterol (SUCRA: 86.56%).
  • With regard to cholesterol and HDL cholesterol levels, xylo-oligosaccharides (SUCRA: 84.59%) and gum arabic (SUCRA: 89.06%) were the most effective fibers.
meta-analysisn=927
DOI

Yu J et al. • Nutrients (2022)

“This meta-analysis supports the health benefits of oat beta-glucan, especially for its cholesterol-lowering features, although it has some inevitable limitations.”
Key Findings:
  • The results were presented with the weighted mean difference (WMD) with a 95% CI.
  • Overall, oat beta-glucan supplementation significantly reduced levels of TC (pooled WMD = -0.24 mmol/L; 95%CI: -0.28 to -0.20 mmol/L), LDL-c (pooled WMD = -0.27 mmol/L; 95%CI: -0.35 to -0.20 mmol/L).
  • Furthermore, beta-glucan consumption did not show significant effects on TG (pooled WMD = -0.04 mmol/L; 95%CI: -0.13 to 0.05 mmol/L), HDL-c (pooled WMD = 0.00 mmol/L; 95%CI: -0.05 to 0.05 mmol/L).
meta-analysisn=603
DOI

Zou Y et al. • International journal of food sciences and nutrition (2015)

“In conclusion, there was not a significant overall effect of beta-glucan intake on improvements of fasting glucose and insulin concentrations in hypercholesterolemic subjects.”
Key Findings:
  • Summary estimates of weighted mean differences (WMD) and 95% confidence interval was 0.05 mmol/L (-0.11, 0.02) for fasting glucose concentration and 0.75 pmol/L (-1.82, 3.32) for fasting insulin concentrations.
  • Twelve trials with a total of 603 subjects were included in the meta-analysis.
  • Beta-glucan consumption did not significantly affect measures of glycemic control.
  • In conclusion, there was not a significant overall effect of beta-glucan intake on improvements of fasting glucose and insulin concentrations in hypercholesterolemic subjects.
systematic-reviewn=45
DOI

Scafuri L et al. • Nutrients (2025)

“However, the evidence is mixed across supplement types, and further research is needed to determine the most effective and safe approaches.”
Key Findings:
  • Curcumin studies presented mixed results.
  • Silymarin showed potential for hepatoprotective effects.
  • Conclusions: These findings highlight the potential of specific dietary supplements to improve various aspects of breast cancer care.
  • However, the evidence is mixed across supplement types, and further research is needed to determine the most effective and safe approaches.
meta-analysisn=1731
DOI

Li A et al. • Food & function (2024)

“Conclusions: Oat-based products may reduce TC and LDL-C, but have little effect on TG, HDL-C, and major cardiovascular events in patients with dyslipidemia.”
Key Findings:
  • Pooled estimates showed that oat-based products may result in a large reduction in LDL-C (WMD, -0.24 mmol L-1; 95% CI: -0.33, -0.15) (moderate certainty) and TC (WMD, -0.32 mmol L-1; 95% CI: -0.48, -0.17) (moderate certainty).
  • Compared to other diets (mainly other cereals), oat-based products probably reduce the level of LDL-C (WMD, -0.17 mmol L-1; 95% CI: -0.25, -0.08) (moderate certainty) and TC (WMD, -0.21 mmol L-1; 95% CI: -0.30, -0.12) (moderate certainty).
  • Both groups showed that oat-based products had little effect on HDL-C and TG (moderate certainty).
  • Oat-related adverse events were mostly gastrointestinal such as diarrhea, nausea, and flatulence being the most prevalent.
40
Total Studies
9.0/10
Avg Quality
10-2,685
Sample Size Range
2007-2025
Research Span

Study Type Distribution

Meta-Analysis
19
RCT
14
Systematic Review
7

This information is for educational purposes only and is not intended as medical advice. Always consult a qualified healthcare provider before starting any supplement.